| scholarly article | Q13442814 |
| P2093 | author name string | Aleksandra Jotic | |
| Katarina Lalic | |||
| Ljiljana Lukic | |||
| Natasa Rajkovic | |||
| Nebojsa M Lalic | |||
| Tanja Milicic | |||
| Ljubica Stosic | |||
| Miroslava Zamaklar | |||
| Sandra Singh | |||
| P2860 | cites work | Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin | Q22010955 |
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Evidence of a causal relationship between adiponectin levels and insulin sensitivity: a Mendelian randomization study | Q30538088 | ||
| Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients | Q33868771 | ||
| Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. | Q33918774 | ||
| Leptin deficiency causes insulin resistance induced by uncontrolled diabetes | Q33930217 | ||
| Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia | Q33946056 | ||
| Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients | Q79791438 | ||
| Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study | Q79988015 | ||
| Evaluation of oxidative stress and inflammation in obese adults with metabolic syndrome | Q46735067 | ||
| Parameters of inflammation in morbid obesity: lack of effect of moderate weight loss. | Q47204962 | ||
| The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? | Q47288086 | ||
| A randomised trial of a weight loss intervention for overweight and obese people diagnosed with coronary heart disease and/or type 2 diabetes | Q47312315 | ||
| Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus | Q50538129 | ||
| Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients | Q51555890 | ||
| Relation Between Plasma Tumor Necrosis Factor-α and Insulin Sensitivity in Elderly Men With Non–Insulin-Dependent Diabetes Mellitus | Q51568409 | ||
| Resistin is an inflammatory marker of atherosclerosis in humans | Q53870894 | ||
| Serum Levels of Tumor Necrosis Factor-α Are Increased in Obese Patients with Noninsulin-Dependent Diabetes Mellitus1 | Q54144879 | ||
| Leptin is reduced in lean subjects with type 2 diabetes in bangladesh | Q57938596 | ||
| Leptin Therapy Does Not Affect Inflammatory Markers | Q58284080 | ||
| Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans | Q63866263 | ||
| C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women | Q74845466 | ||
| Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals | Q77463126 | ||
| Correlation between serum resistin level and adiposity in obese individuals | Q33967739 | ||
| Intensive weight loss intervention in older individuals: results from the Action for Health in Diabetes Type 2 diabetes mellitus trial | Q34010035 | ||
| Effect of Aerobic Interval Training on Exercise Capacity and Metabolic Risk Factors in People With Cardiometabolic Disorders | Q34030269 | ||
| Adipose tissue, inflammation and atherosclerosis | Q34096337 | ||
| Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance | Q34265623 | ||
| Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects | Q34269697 | ||
| Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes | Q34283092 | ||
| Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects | Q34311869 | ||
| Obesity, adiponectin and vascular inflammatory disease | Q35587168 | ||
| Circulating Levels of TNF-α Are Associated with Impaired Glucose Tolerance, Increased Insulin Resistance, and Ethnicity: The Insulin Resistance Atherosclerosis Study | Q35869657 | ||
| Inflammatory mechanisms in the regulation of insulin resistance | Q36409227 | ||
| Recent advances in the relationship between obesity, inflammation, and insulin resistance. | Q36448850 | ||
| Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register | Q36825718 | ||
| Low serum adiponectin concentrations are associated with insulin sensitivity independent of obesity in Sudanese subjects with type 2 diabetes mellitus | Q36885255 | ||
| The endothelium and vascular inflammation in diabetes | Q36892486 | ||
| Serum Leptin Level is Reduced in Non-Obese Subjects with Type 2 Diabetes | Q36957442 | ||
| The evolving role of C-reactive protein in atherothrombosis | Q37144130 | ||
| Adipose tissue dysfunction in obesity, diabetes, and vascular diseases | Q37262617 | ||
| Inflammation and type 2 diabetes | Q37976544 | ||
| Role of adipokines in cardiovascular disease | Q38060575 | ||
| Plasma resistin, insulin concentration in non-diabetic and diabetic, overweight/obese Thai | Q38308457 | ||
| Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes | Q38318585 | ||
| Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus. | Q38320151 | ||
| Independent association between plasma leptin and C-reactive protein in healthy humans | Q38341904 | ||
| Type 2 diabetes in non-obese Indian subjects is associated with reduced leptin levels: study from Mumbai, Western India | Q39738765 | ||
| Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS Pathway | Q39788216 | ||
| Plasma leptin and prognosis in patients with established coronary atherosclerosis. | Q40471451 | ||
| High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians | Q40514603 | ||
| Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year | Q42517667 | ||
| Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons. | Q43595875 | ||
| Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) | Q43826703 | ||
| Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. | Q43887376 | ||
| Low-molecular-weight adiponectin and high-molecular-weight adiponectin levels in relation to diabetes | Q43889990 | ||
| Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro | Q43982432 | ||
| Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. | Q44075438 | ||
| Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. | Q44398229 | ||
| Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus | Q44723039 | ||
| Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes | Q45081266 | ||
| Associations of resistin with inflammatory and fibrinolytic markers, insulin resistance, and metabolic syndrome in middle-aged and older Chinese | Q46407084 | ||
| Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity | Q46535857 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | obesity | Q12174 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 4049-4065 | |
| P577 | publication date | 2014-04-14 | |
| P1433 | published in | International Journal of Environmental Research and Public Health | Q6051382 |
| P1476 | title | Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk prevention | |
| P478 | volume | 11 |
| Q42616529 | Adipokine Profile in Patients with Type 2 Diabetes Depends on Degree of Obesity. |
| Q36907277 | Association of serum leptin and adiponectin with anthropomorphic indices of obesity, blood lipids and insulin resistance in a Sub-Saharan African population |
| Q61443992 | Blood-brain barrier permeability and physical exercise |
| Q26991652 | Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease |
| Q55284990 | Correlation of Serum Adiponectin and Leptin levels in Obesity and Type 2 Diabetes Mellitus. |
| Q92645684 | Correlation of serum adipocytokine levels with glycolipid metabolism and inflammatory factors in obese patients with periodontal disease |
| Q92662062 | Diets along with interval training regimes improves inflammatory & anti-inflammatory condition in obesity with type 2 diabetes subjects |
| Q50236014 | Effects of metformin treatment on blood leptin and ghrelin levels in patients with type 2 diabetes mellitus |
| Q48195453 | Effects of pioglitazone treatment on blood leptin levels in patients with type 2 diabetes. |
| Q91604284 | Evaluation of Proinflammatory Cytokines in Obese vs Non-obese Patients with Metabolic Syndrome |
| Q38830118 | Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer's disease in T2DM patients |
| Q97519952 | Genetic determinants of obesity heterogeneity in type II diabetes |
| Q34344972 | Immuno-modulator metallo-Peptide reduces inflammatory state in obese zucker fa/fa rats |
| Q92708651 | Incidence and effect of insulin resistance on progression of atherosclerosis in rheumatoid arthritis patients of long disease duration |
| Q58594757 | Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population |
| Q39017257 | Leptin but not adiponectin is related to type 2 diabetes mellitus in obese adolescents |
| Q30239799 | MAP4K4 and IL-6+ Th17 cells play important roles in non-obese type 2 diabetes |
| Q36835250 | Maternal and Fetal Lipid and Adipokine Profiles and Their Association with Obesity |
| Q34769260 | Metabolic and inflammatory genes in schizophrenia |
| Q41718751 | Non-alcoholic fatty liver disease associated with increased arterial stiffness in subjects with normal glucose tolerance, but not pre-diabetes and diabetes |
| Q38282228 | Obesity and kidney disease: differential effects of obesity on adipose tissue and kidney inflammation and fibrosis |
Search more.